EUVIMEDEUVIMED entdecken
VergleichsstudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

A controlled trial comparing dosimetry and radiation pneumonitis between tomotherapy and IMRT in patients with lung or esophageal cancer

Anmei Zhang, Yang Zhang, Jingyun Yang, Lu Chen, Na Wu, Jindong Qian, Hongya Dai, Dingqiang Yang, Lirong Zhao, Liangzhi Zhong, Tianxiang Cui, Fan Yang und 4 weitere

Journal of Applied Clinical Medical Physics · 2026-03 · 27 (3)

DOI: 10.1002/acm2.70537 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Applied Clinical Medical Physics, online erschienen am 18.03.2026. Verfasst von Anmei Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Xinqiao Hospital, Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Radiotherapy, Intensity-Modulated, Radiation Pneumonitis, Esophageal Neoplasms, Lung Neoplasms. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science-Health Joint Medical Scientific Research Project of Chongqing, Natural Science Foundation of Chongqing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Backgroud The expanding clinical use of helical tomotherapy (HT) has raised concerns regarding its potential to increase low‐dose lung exposure and the risk of radiation pneumonitis (RP) in thoracic radiotherapy. While a few retrospective studies have compared dosimetric parameters and RP rates between HT and fixed‐field intensity‐modulated radiation therapy (IMRT), their findings remain inconsistent, necessitating a prospective randomized controlled trial for clarification.

Purpose

To prospectively compare dosimetric parameters and the incidence of RP between HT and IMRT in patients with lung or esophageal cancer.

Methods

Patients eligible for thoracic radiotherapy were enrolled. Both HT and IMRT plans were designed and optimized for each patient, with a prescription equivalent dose in 2 Gy /fraction (EQD2) ≥50 Gy to the gross tumor volume (GTV). Plans were evaluated based on target dose coverage, dose‐volume histograms, and other dosimetric indices. RP was diagnosed and graded according to the Common Terminology Criteria for Adverse Events (version 5.0). Risk factors for RP were identified using univariate analysis.

Results

Between February and September 2022, 110 consecutive patients with lung or esophageal cancer were enrolled and randomly assigned in a 1:1 ratio to either the HT group ( n = 54) or the IMRT group ( n = 56). Compared with IMRT, HT had a significant reduction in lung V20 ( p = 0.002) and mean lung dose ( p = 0.013). Furthermore, the HT group exhibited a superior conformity index for the planning gross tumor volume of the primary lesion (PGTVp) ( p = 0.004) and a lower homogeneity index for all planning target volumes (PTVs) ( p < 0.001). At a median follow‐up of 14.0 months, the rate of grade≥2 RP for the entire cohort was 14.5%, with no significant differences between the HT and IMRT groups ( p = 0.61).

Conclusions

Compared with fixed‐field IMRT, HT provided superior dose distribution to the PTVs while maintaining a comparable incidence of RP in patients undergoing thoracic radiotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiotherapy, Intensity-ModulatedRadiation PneumonitisEsophageal NeoplasmsLung NeoplasmsRadiotherapy Planning, Computer-AssistedHumansFemaleRadiotherapy DosageMaleOrgans at RiskMiddle AgedAgedProspective StudiesRadiometryPrognosisAged, 80 and overAdultFollow-Up Studies

Stichwörter der Autor:innen

IMRTdosimetryhelical tomotherapyradiation pneumonitisthoracic radiation

Autor:innen und Institutionen

  • Department of Oncology, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Department of Epidemiology, College of Preventive Medicine, Army Medical University, Chongqing, China.

ORCID-Profile: Guanghui Li

Förderung

  • Science-Health Joint Medical Scientific Research Project of Chongqing
  • Natural Science Foundation of Chongqing

Zitieren

APA

Zhang, A., Zhang, Y., Yang, J., Chen, L., Wu, N., Qian, J., Dai, H., Yang, D., Zhao, L., Zhong, L., Cui, T., Yang, F., Chen, G., Gao, Y., Luo, W., & Li, G. (2026). A controlled trial comparing dosimetry and radiation pneumonitis between tomotherapy and IMRT in patients with lung or esophageal cancer. Journal of Applied Clinical Medical Physics, 27(3). https://doi.org/10.1002/acm2.70537

Vancouver

Zhang A, Zhang Y, Yang J, Chen L, Wu N, Qian J, et al. A controlled trial comparing dosimetry and radiation pneumonitis between tomotherapy and IMRT in patients with lung or esophageal cancer. Journal of Applied Clinical Medical Physics. 2026;27(3). doi:10.1002/acm2.70537

BibTeX
@article{Zhang2026,
  author = {Zhang, Anmei and Zhang, Yang and Yang, Jingyun and Chen, Lu and Wu, Na and Qian, Jindong and Dai, Hongya and Yang, Dingqiang and Zhao, Lirong and Zhong, Liangzhi and Cui, Tianxiang and Yang, Fan and Chen, Guangpeng and Gao, Yixing and Luo, Wen and Li, Guanghui},
  title = {A controlled trial comparing dosimetry and radiation pneumonitis between tomotherapy and IMRT in patients with lung or esophageal cancer},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2026},
  volume = {27},
  number = {3},
  doi = {10.1002/acm2.70537}
}
Kostenlos starten →